NICE recommends Novartis\' gene therapy Luxturna for inherited retinal dystrophy httpbit.ly2lXV8Ae pharmapic.twitter.comHYbbZXBeLF

NICE recommends Novartis' gene therapy Luxturna for inherited retinal dystrophy http://bit.ly/2lXV8Ae  #pharmapic.twitter.com/HYbbZXBeLF

07:30 EDT 4 Sep 2019 | Pharmafile

NICE recommends Novartis' gene therapy Luxturna for inherited retinal dystrophy http://bit.ly/2lXV8Ae  #pharma pic.twitter.com/HYbbZXBeLF

More From BioPortfolio on "NICE recommends Novartis' gene therapy Luxturna for inherited retinal dystrophy http://bit.ly/2lXV8Ae  #pharmapic.twitter.com/HYbbZXBeLF"